IP Library Granted Patent US 11,835,435
Granted Patent B2
US 11,835,435 · App. 16/696,348 · Granted Dec 5, 2023

Systems and methods for detecting a health condition

Inventors: Gregory J. Sherwood (North Oaks, MN); Justin Theodore Nelson (Minneapolis, MN)
Assignee: REGENTS OF THE UNIVERSITY OF MINNESOTA
G01N1/2226G01N27/22G16H15/00G16H20/00G16H50/20G16H50/30G01N2001/2229G01N2027/222
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,835,435
App. No.
16/696,348
Granted
Dec 5, 2023
Kind
B2
Abstract

Embodiments herein include a method for detecting a health condition of a subject. The method can include obtaining a biological sample from the subject and placing it into a container having a headspace surrounding the biological sample. The method can include contacting a gas from the headspace with a chemical sensor element, the chemical sensor element including one or more discrete graphene varactors. The method can include sensing and storing capacitance of the discrete graphene varactors to obtain a sample data set. Other embodiments are also included herein.

Claims (48)

1. A method for detecting a health condition of a subject, comprising:

obtaining a biological sample from the subject and placing it into a container having a headspace surrounding the biological sample;

contacting a gas from the headspace with a chemical sensor element, the chemical sensor element comprising one or more discrete graphene varactors, wherein volatile organic compounds (VOCs) from the biological sample that are present in the gas from the headspace interface with the discrete graphene varactors to influence sensed capacitance; and

sensing and storing capacitance of the discrete graphene varactors to obtain a sample data set,

wherein obtaining a biological sample comprises obtaining one or more of an organ biopsy, blood, urine, bile, sweat, feces, lymph, cerebrospinal fluid, amniotic fluid, pericardial fluid, peritoneal fluid, saliva, synovial fluid, serous fluid, sebum, bone biopsy, muscle biopsy, cheek swab biopsy, or isolated cells.

2. The method of claim 1 , classifying the sample data set into one or more preestablished classifications.

3. The method of claim 2 , further comprising identifying a therapy to treat the subject based on the preestablished classification.

4. The method of claim 1 , wherein the headspace above or around the biological sample includes a volume of a gas.

5. The method of claim 1 , wherein the container is flushed with an inert gas prior to placing the biological sample into the container.

6. The method of claim 1 , the container comprising a sample port, wherein the biological sample is placed into the container through the sample port.

7. The method of claim 1 , wherein the gas from the headspace is continuously drawn from the container and contacted with the chemical sensor element.

8. The method of claim 1 , wherein the biological sample is incubated in the container for a period of time before the gas from the headspace is contacted with a chemical sensor element.

9. The method of claim 1 , wherein the biological sample is heated to a temperature in the range of 25 degrees C. to 40 degrees C. prior to contacting the headspace with a chemical sensor element.

10. The method of claim 1 , wherein sensing and storing capacitance of the graphene varactors to obtain a sample data set is performed across a range of bias voltages, wherein the range of bias voltages is from −3 V to 3 V.

11. The method of claim 1 , further storing additional data regarding the subject beyond sensed capacitance as part of the sample data set that is classified, the additional data comprising at least one of:

prior disease states of the subject;

age of the subject;

results of a physical examination;

symptoms experienced by the subject; and

data regarding specific biomarkers of one or more disease states.

12. A method for detecting a health condition of a subject, comprising:

obtaining a biological sample from the subject and placing it into a container having a headspace surrounding the biological sample;

heating the biological sample to a temperature in the range of 25 degrees C. to 40 degrees C. prior to contacting the headspace with a chemical sensor element;

contacting a gas from the headspace with a chemical sensor element, the chemical sensor element comprising one or more discrete graphene varactors, wherein volatile organic compounds (VOCs) from the biological sample that are present in the gas from the headspace interface with the discrete graphene varactors to influence sensed capacitance; and

sensing and storing capacitance of the discrete graphene varactors to obtain a sample data set,

wherein the biological sample is heated to a temperature in the range of 25 degrees C. to 40 degrees C. prior to contacting the headspace with a chemical sensor element.

13. The method of claim 12 , classifying the sample data set into one or more preestablished classifications.

14. The method of claim 13 , further comprising identifying a therapy to treat the subject based on the preestablished classification.

15. The method of claim 12 , wherein the biological sample is incubated in the container for a period of time before the gas from the headspace is contacted with a chemical sensor element.

16. The method of claim 12 , further storing additional data regarding the subject beyond sensed capacitance as part of the sample data set that is classified, the additional data comprising at least one of:

prior disease states of the subject;

age of the subject;

results of a physical examination;

symptoms experienced by the subject; and

data regarding specific biomarkers of one or more disease states.

17. A method for detecting a health condition of a subject, comprising:

obtaining a biological sample from the subject and placing it into a container having a headspace surrounding the biological sample;

contacting a gas from the headspace with a chemical sensor element, the chemical sensor element comprising one or more discrete graphene varactors, wherein volatile organic compounds (VOCs) from the biological sample that are present in the gas from the headspace interface with the discrete graphene varactors to influence sensed capacitance;

sensing and storing capacitance of the discrete graphene varactors to obtain a sample data set; and

storing additional data regarding the subject beyond sensed capacitance as part of the sample data set that is classified, the additional data comprising at least one of:

prior disease states of the subject;

age of the subject;

results of a physical examination;

symptoms experienced by the subject; and

data regarding specific biomarkers of one or more disease states.

18. The method of claim 17 , classifying the sample data set into one or more preestablished classifications.

19. The method of claim 18 , further comprising identifying a therapy to treat the subject based on the preestablished classification.

20. The method of claim 17 , wherein the biological sample is incubated in the container for a period of time before the gas from the headspace is contacted with a chemical sensor element.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 25, 2023
From: BOSTON SCIENTIFIC SCIMED, INC.
To: REGENTS OF THE UNIVERSITY OF MINNESOTA
Reel/Frame 064372/0089 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 27, 2020
From: SHERWOOD, GREGORY J.; NELSON, JUSTIN THEODORE
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 051946/0523 →
Continuity (2)
Provisional Application 62771856 · Nov 27, 2018
Related Publication 20200166435A1 · May 28, 2020
Cited By (3)
US 12,480,907 US 12,523,626 US 12,613,212